Business Services
Medical
Therapy

Adaptive Biotechnologies

2,749

$28.13
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.62 (+2.25%) Today
$0.00 (0.00%) As of 4:28 AM EDT after-hours

Why Robinhood?

You can buy or sell ADPT and other stocks, options, ETFs, and crypto commission-free!

About ADPT

Adaptive Biotechnologies Corp. engages in the development of an immune medicine platform. It harnesses the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Read More Its products and services include immunoSEQ, clonoSEQ, cellular therapy, and vaccines. The company was founded by Chad Robins, Harlan Robins, and Chris Carlson in September 2009 and is headquartered in Seattle, WA.

CEO
Chad Robins
Employees
453
Headquarters
Seattle, Washington
Founded
2009
Market Cap
3.55B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.37M
High Today
$28.54
Low Today
$26.77
Open Price
$27.79
Volume
1.03M
52 Week High
$55.12
52 Week Low
$15.19

Collections

Business Services
Medical
Therapy
Health
2019 IPO
US
North America

ADPT News

MarketWatch19h

Amgen, Adaptive Biotechnologies ink COVID-19 antibody development collaboration

Shares of Amgen Inc. AMGN, -0.62% gained 1.2% in trading on Thursday after the drugmaker announced that it is collaborating with Adaptive Biotechnologies Corp.
147

ADPT Earnings

-$1.23
-$0.82
-$0.41
$0.00
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Estimated
— per share
Actual
Expected May 6, After Hours

People Also Bought

Precision BioSciences

6,203

$5.54

+5.12%

Precision BioSciences

6,203

$5.54

+5.12%

SmileDirectClub

36,852

$4.15

-0.24%

Livongo

9,392

$26.30

-5.40%

Hexo

178,599

$0.717

+4.52%

You May Also Like

SLDB
NJV
SLG
NEE-K
VKQ
MVF
OMC
PNNT
TMSNY
NTIP
Robinhood Snacks newsletters and podcasts reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are meant for informational purposes only, are not intended to serve as a recommendation to buy or sell any security in a self-directed Robinhood account or any other account, and are not an offer or sale of a security. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. The price of a given security may increase or decrease based on market conditions and customers may lose money, including their original investment. Robinhood Financial LLC, member FINRA/SIPC.

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.

Buy ADPT

Market Price$28.13
Commissions$0.00
Estimated Cost
$0.00
Sign up for a Robinhood Account to buy or sell ADPT stock and options commission-free.
Search
LearnBlogCareersHelpLog InSign Up